Profile
EVAX VRTX ALNY REGN ARGX SGEN
Company Name Evaxion Biotech A/S Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $43.90M $100.41B $59.77B $58.74B $48.87B $43.15B
Employees 0.05K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO Christian Kanstrup Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
EVAX VRTX ALNY REGN ARGX SGEN
Quant Rating Score 1 3 1 4 3 3
Quant Rating Strong Sell Neutral Strong Sell Buy Neutral Neutral
Trading
EVAX VRTX ALNY REGN ARGX SGEN
Last Close $6.29 $421.15 $450.68 $563.86 $798.94 $228.74
High 52 $6.94 $516.74 $482.13 $1016.53 $800 $228.74
Low 52 $0.85 $366.54 $224.58 $482.92 $520.52 $228.74
Price vs. 52 Week High -9.37 % -18.5 % -6.52 % -44.53 % -0.13 % 0 %
Price vs. 52 Week Low 640 % 14.9 % 100.68 % 16.76 % 53.49 % 0 %
Total Return
EVAX VRTX ALNY REGN ARGX SGEN
1 Month Return 124.64 % 6.22 % -6.52 % 1.32 % 4.1 % 0 %
3 Month Return 148.62 % -12.07 % 40.53 % 2.06 % 43.9 % 0 %
6 Month Return 372.93 % -12.68 % 85.28 % -2.14 % 41.7 % 0 %
9 Month Return 606.74 % 2.19 % 87.35 % -23.14 % 23.05 % 0 %
YTD Return 644.03 % 4.58 % 91.53 % -20.84 % 29.91 % 0 %
1 Year Return 134.7 % -10 % 66.36 % -44.29 % 53.49 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
EVAX VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.47 % - -
Dividend Paid and Capex Coverage Ration (TTM) - 11.09 % -0.43 % 4.37 % 65.28 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Profitability
EVAX VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM 100 % 86.11 % 83.64 % 81.98 % 65.82 % 79.1 %
Return on Assets TTM -53.37 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM -320.16 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM -81.56 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 94.05 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 91.2 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM -438.5 % 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM - 251.83 % -1.2 % 175.35 % 932.29 % -1043.73 %
Receivables Turnover TTM 3.69 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM - 3.59 3.93 3.54 0.9 1.97
Inventory Turnover TTM - 1.06 5.62 0.8 2.26 0.96
Fixed Asset Turnover TTM 87.92 % 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM 14.19 % 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM - 14.98 -0.12 45.13 5.67 -2.46
Free Cash Flow Per Share TTM - 13.63 -0.4 36.58 5.58 -2.88
Cash Per Share TTM 305.24 % 2486.48 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM - 33.68 % -0.63 % 33.37 % 17.54 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM - 90.99 % 335.21 % 81.05 % 98.47 % 117.04 %
Cash Flow Coverage Ratios TTM - 251.83 % -1.2 % 175.35 % 932.29 % -1043.73 %
Price To Free Cash Flows Ratio TTM - 28.69 -1147.52 15.28 122.57 -81.26
Price To Operating Cash Flows Ratio TTM - 26.14 -3805.41 12.49 140 -93.1
Price Cash Flow Ratio TTM - 26.14 -3805.41 12.49 140 -93.1
Income Statement (TTM)
EVAX VRTX ALNY REGN ARGX SGEN
Revenue $0B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $0B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio 100% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $-0.01B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0.01B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -9.8 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
EVAX VRTX ALNY REGN ARGX SGEN
Long Term Debt $0.01B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $0.01B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $-0B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $0.01B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $0.01B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
EVAX VRTX ALNY REGN ARGX SGEN
Net Income $-0.01B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $0B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $0B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 37.1349
AARD Aardvark Therapeutics, Inc. Common Stock 16.74
ABCL AbCellera Biologics Inc. 5.915
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.685
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.16
ABPWW 0.0255
ABSI Absci Corporation 4.015
ABUS Arbutus Biopharma Corporation 4.195
ABVC ABVC BioPharma, Inc. 3.2801
ABVX Abivax SA American Depositary Shares 90.4
ACAD ACADIA Pharmaceuticals Inc. 20.685
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.9177
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 3.295
ACIU AC Immune SA 3.51
Unlock